| Drugname |
Patent Number |
Patent Title |
Patent Assignee |
Estimated Expiration |
| Alisertib |
➤ Sign Up |
Aurora kinase inhibitors for inhibiting mitotic progression |
Millennium Pharmaceuticials, Inc. (Cambridge, MA) |
➤ Sign Up |
| Alisertib |
➤ Sign Up |
Crystalline forms of sodium 4-{[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-D][2]benzazepin- -2-yl]amino}-2-methoxybenzoate |
Millennium Pharmaceuticals, Inc. (Cambridge, MA) |
➤ Sign Up |
| Alisertib |
➤ Sign Up |
Pharmaceutical compositions for the treatment of cancer and other diseases or disorders |
Millennium Pharmaceuticals, Inc. (Cambridge, MA) |
➤ Sign Up |
| Alisertib |
➤ Sign Up |
Solid pharmaceutical compositions and processes for their production |
MILLENNIUM PHARMACEUTICALS, INC. (Cambridge, MA) |
➤ Sign Up |
| Alisertib |
➤ Sign Up |
Tetrazolones as a carboxylic acid bioisosteres |
Rigel Pharmaceuticals, Inc. (South San Francisco, CA) |
➤ Sign Up |
| Alisertib |
➤ Sign Up |
Pharmaceutical compositions for the treatment of cancer and other diseases or disorders |
Millennium Pharmaceuticals, Inc. (Cambridge, MA) |
➤ Sign Up |
| Drugname |
Patent Number |
Patent Title |
Patent Assignee |
Estimated Expiration |
This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
